Time frame of sentinel node visualization in early breast cancer patients using intradermal injection of Tc-99m phytate: Imaging beyond 45 minutes does not yield more information

Document Type : Original Article

Authors

1 Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

2 Endoscopic & Minimally Invasive Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

Abstract

Introduction: One of the major problems of lymphoscintigraphy is the time of patient presence in the nuclear medicine wards. The operating room schedule can be compromised if the patients stay longer than usual in the nuclear medicine departments. However, too early imaging can be falsely negative for sentinel node visualization and delayed imaging may be required. The aim of the current study is to determine a time beyond which lymphoscintigraphy imaging does not yield more information and imaging can be terminated.
Methods: One hundred and fifty women with proven clinically axillary node negative breast cancer entered the study For each patient 0.5 mCi Tc-99m phytate in the 0.2 cc volume was intradermally injected in periareolar region to raise a wheal. Lymphoscintigraphy imaging was done in the following time intervals: 5, 10, 30, 45, 60, 90 minutes post injection. In case of sentinel node visualization at any time, the imaging was terminated.
Results:Sentinel nodes were first detected on 5, 10, 30, 45, 60, and 90 minute images in 31 (20.6%), 45 (30%), 46 (30.6%), 15 (10%), 1 (0.6%), and 0 patients. Median number of the detected sentinel nodes per patient was 1. At least one hot sentinel node could be identified in all 138 patients with observed sentinel nodes of whom, 45 had pathologically involved sentinel nodes and axillary lymph node dissection was done. In 12 patients, no sentinel node was visualized even on the 90 minute images. All of these patients had axillary node involvement and no sentinel node could be harvested intra-operatively either.

Conclusion: Considering the rather slow movement of Tc-99m phytate in the lymphatic system, lymphoscintigraphy imaging of the breast cancer patients should be continued for 45 minutes in case of sentinel node detection failure. On the other hand imaging beyond 45 minutes does not seem to be necessary as the diagnostic yield is very low.

Keywords

Main Subjects

References

  1. Nathanson SD, Grogan JK, DeBruyn D, Kapke A, Karvelis K. Breast cancer sentinel lymph node identification rates: the influence of radiocolloid mapping, case volume, and the place of the procedure. Ann Surg Oncol. 2007 May;14(5):1629-37.
  2. Newman EA, Newman LA. Lymphatic mapping techniques and sentinel lymph node biopsy in breast cancer. Surg Clin North Am. 2007 Apr;87(2):353-64, viii.
  3. Newman LA. Lymphatic mapping and sentinel lymph node biopsy in breast cancer patients: a comprehensive review of variations in performance and technique. J Am Coll Surg. 2004 Nov;199(5):804-16.
  4. Zarifmahmoudi L, Shabahang H, Shariati F, Dabbagh Kakhki VR, Mehrabibahar M, Sadat Alavifard R, Jangjoo A, Sadeghi R. Dynamic lymphoscintigraphy in breast cancer patients: feasibility and added value. Iran J Nucl Med. 2016;24(2):130-5.
  5. Kim CK, Zukotynski KA. Desirable Properties of Radiopharmaceuticals for Sentinel Node Mapping in Patients With Breast Cancer Given the Paradigm Shift in Patient Management. Clin Nucl Med. 2017 Apr;42(4):275-279.
  6. Bromham N, Schmidt-Hansen M, Astin M, Hasler E, Reed MW. Axillary treatment for operable primary breast cancer. Cochrane Database Syst Rev. 2017 Jan 4;1:CD004561.
  7. Kadkhodayan S, Hasanzadeh M, Treglia G, Azad A, Yousefi Z, Zarifmahmoudi L, Sadeghi R. Sentinel node biopsy for lymph nodal staging of uterine cervix cancer: a systematic review and meta-analysis of the pertinent literature. Eur J Surg Oncol. 2015 Jan;41(1):1-20.
  8. Hassanzade M, Attaran M, Treglia G, Yousefi Z, Sadeghi R. Lymphatic mapping and sentinel node biopsy in squamous cell carcinoma of the vulva: systematic review and meta-analysis of the literature. Gynecol Oncol. 2013 Jul;130(1):237-45.
  9. Ansari M, Rad MA, Hassanzadeh M, Gholami H, Yousefi Z, Dabbagh VR, Sadeghi R. Sentinel node biopsy in endometrial cancer: systematic review and meta-analysis of the literature. Eur J Gynaecol Oncol. 2013;34(5):387-401.
  10. Sadeghi R, Gholami H, Zakavi SR, Kakhki VR, Tabasi KT, Horenblas S. Accuracy of sentinel lymph node biopsy for inguinal lymph node staging of penile squamous cell carcinoma: systematic review and meta-analysis of the literature. J Urol. 2012 Jan;187(1):25-31.
  11. Sadeghi R, Tabasi KT, Bazaz SM, Kakhki VR, Massoom AF, Gholami H, Zakavi SR. Sentinel node mapping in the prostate cancer. Meta-analysis. Nuklearmedizin. 2011;50(3):107-15.
  12. Dabbagh Kakhki VR, Bagheri R, Tehranian S, Shojaei P, Gholami H, Sadeghi R, Krag DN. Accuracy of sentinel node biopsy in esophageal carcinoma: a systematic review and meta-analysis of the pertinent literature. Surg Today. 2014 Apr;44(4):607-19.
  13. Bagheri R, Naghavi F, Dabbagh Kakhki VR, Zakavi SR, Fattahi AS, Jafarian AH, Haghi SZ, Sadeghi R. Sentinel node mapping in esophageal squamous cell carcinoma using intra-operative combined blue dye and radiotracer techniques. Esophagus. 2013;10(4):211-6.
  14. Taghizadeh Kermani A, Bagheri R, Tehranian S, Shojaee P, Sadeghi R, N Krag D. Accuracy of sentinel node biopsy in the staging of non-small cell lung carcinomas: systematic review and meta-analysis of the literature. Lung Cancer. 2013 Apr;80(1):5-14.
  15. Lawson LL, Sandler M, Martin W, Beauchamp RD, Kelley MC. Preoperative lymphoscintigraphy and internal mammary sentinel lymph node biopsy do not enhance the accuracy of lymphatic mapping for breast cancer. Am Surg. 2004 Dec;70(12):1050-5; discussion 1055-6.
  16. Sadeghi R, Forghani MN, Memar B, Abdollahi A, Zakavi SR, Mashhadi MT, Raziee HR, Tavassoli A, Kakhki VR. Comparison of pre-operative lymphoscintigraphy with inter-operative gamma probe and dye technique regarding the number of detected sentinel lymph nodes. Hell J Nucl Med. 2009 Jan-Apr;12(1):30-2.
  17. Eldrageely K, Vargas MP, Khalkhali I, Venegas R, Burla M, Gonzalez KD, Vargas HI. Sentinel lymph node mapping of breast cancer: a case-control study of methylene blue tracer compared to isosulfan blue. Am Surg. 2004 Oct;70(10):872-5.
  18. Sadeghi R, Alesheikh G, Zakavi SR, Fattahi A, Abdollahi A, Assadi M, Jangjoo A, Keshtgar M. Added value of blue dye injection in sentinel node biopsy of breast cancer patients: do all patients need blue dye? Int J Surg. 2014;12(4):325-8.
  19. Aliakbarian M, Memar B, Jangjoo A, Zakavi SR, Reza Dabbagh Kakhki V, Aryana K, Forghani MN, Sadeghi R. Factors influencing the time of sentinel node visualization in breast cancer patients using intradermal injection of the radiotracer. Am J Surg. 2011 Aug;202(2):199-202.
  20. Dabbagh Kakhki VR, Jangjoo A, Tavassoli A, Asadi M, Sadri K, Fatahi Masoom A, Mehrabibahar M, Memar B, Ansari M, Sadeghi R. Sentinel node mapping for early breast cancer patients using 99mTc-phytate: Single center experience on 165 patients. Iran J Nucl Med. 2012;20(2):25-9.
  21. Jangjoo A, Forghani MN, Mehrabibahar M, Rezapanah A, Kakhki VR, Zakavi SR, Ghavamnasiri MR, Kashani I, Hashemian F, Sadeghi R. Comparison of early and delayed lymphoscintigraphy images of early breast cancer patients undergoing sentinel node mapping. Nucl Med Commun. 2010 Jun;31(6):521-5.
  22. Sadeghi R, Forghani MN, Memar B, Rajabi Mashhadi MT, Dabbagh Kakhki VR, Abdollahi A, Zakavi SR. How long the lymphoscintigraphy imaging should be continued for sentinel lymph node mapping? Ann Nucl Med. 2009 Aug;23(6):507-10.
  23. Mehrabibahar M, Azizi S, Jangjoo A, Saremi E, Kakhki VR, Sadeghi R, Chicken DW, Keshtgar M. Concordance between peri-areolar blue dye and peri-incisional radiotracer injections for sentinel node mapping in patients with a history of primary breast cancer excisonal biopsy. Acta Chir Belg. 2014 Jan-Feb;114(1):31-3.
  24. Sadeghi R, Asadi M, Treglia G, Zakavi SR, Fattahi A, Krag DN. Determining axillary concordance rate for different injection locations in sentinel node mapping of breast cancer: how ambitious can we get? Breast Cancer Res Treat. 2014 Jul;146(1):231-2.
  25. Sadeghi R, Asadi M, Treglia G, Zakavi SR, Fattahi A, Krag DN. Axillary concordance between superficial and deep sentinel node mapping material injections in breast cancer patients: systematic review and meta-analysis of the literature. Breast Cancer Res Treat. 2014 Apr;144(2):213-22.
  26. Higashi H, Natsugoe S, Uenosono Y, Ehi K, Arigami T, Nakabeppu Y, Nakajo M, Aikou T.Particle size of tin and phytate colloid in sentinel node identification. J Surg Res. 2004 Sep;121(1):1-4.
  27. Momennezhad M, Zakavi SR, Dabbagh Kakhki VR, Jangjoo A, Ghavamnasiri MR, Sadeghi R. Scatterogram: a method for outlining the body during lymphoscintigraphy without using external flood source. Radiol Oncol. 2011 Sep;45(3):184-8.
  28. Moghimi M, Ghoddosi I, Rahimabadi AE, Sheikhvatan M. Accuracy of sentinel node biopsy in breast cancer patients with a high prevalence of axillary metastases. Scand J Surg. 2009;98(1):30-3.
  29. Eftekhari M, Beiki D, Fallahi B, Arabi M, Memari F, Gholamrezanezhad A, Esmaili J, Akhzari F, Fard-Esfahani A. Assessment the diagnostic accuracy of sentinel lymph nodes lymphoscintigraphy using Technetium-99m phytate in breast cancer. DARU J Pharma Sci. 2009;17(2):83-7.
  30. Imoto S, Murakami K, Ikeda H, Fukukita H, Moriyama N. Mammary lymphoscintigraphy with various radiopharmaceuticals in breast cancer. Ann Nucl Med. 1999 Oct;13(5):325-9.
  31. Jinno H, Ikeda T, Matsui A, Kitagawa Y, Kitajima M, Fujii H, Nakamura K, Kubo A. Sentinel lymph node biopsy in breast cancer using technetium-99m tin colloids of different sizes. Biomed Pharmacother. 2002;56 Suppl 1:213s-216s.
  32. Abdollahi A, Jangjoo A, Dabbagh Kakhki VR, Rasoul Zakavi S, Memar B, Naser Forghani M, Mehrabibahar M, Sadeghi R. Factors affecting sentinel lymph node detection failure in breast cancer patients using intradermal injection of the tracer. Rev Esp Med Nucl. 2010 Mar-Apr;29(2):73-7.
  33. Tsopelas C. Particle size analysis of (99m)Tc-labeled and unlabeled antimony trisulfide and rhenium sulfide colloids intended for lymphoscintigraphic application. J Nucl Med. 2001 Mar;42(3):460-6.
  34. Ali J, Alireza R, Mostafa M, Naser FM, Bahram M, Ramin S. Comparison between one day and two days protocols for sentinel node mapping of breast cancer patients. Hell J Nucl Med. 2011 Sep-Dec;14(3):313-5.

Files

Share

How to cite

Statistics